NYSE:DVADavita Stock Price, Forecast & News

Davita's stock was trading at $74.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, DVA shares have increased by 6.5% and is now trading at $79.74. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 9 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Davita.

Davita is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Davita.

Davita Inc (NYSE:DVA) announced its quarterly earnings data on Tuesday, May, 5th. The company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.36. The business earned $2.84 billion during the quarter, compared to analysts' expectations of $2.84 billion. Davita had a net margin of 7.85% and a return on equity of 32.45%. The business's quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 EPS. View Davita's earnings history.

Davita issued an update on its FY20 earnings guidance on Tuesday, May, 5th. The company provided earnings per share guidance of $5.75-6.25 for the period, compared to the Thomson Reuters consensus estimate of $6.01. The company issued revenue guidance of $11.5-11.7 billion, compared to the consensus revenue estimate of $11.65 billion.

11 equities research analysts have issued 1-year target prices for Davita's stock. Their forecasts range from $57.00 to $90.00. On average, they expect Davita's share price to reach $68.86 in the next year. This suggests that the stock has a possible downside of 13.6%. View analysts' price targets for Davita.

News articles about DVA stock have been trending somewhat negative recently, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Davita earned a daily sentiment score of -1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Davita.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), The Providence Service (PRSC), Tivity Health (TVTY), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Micron Technology (MU), United Rentals (URI), AutoZone (AZO), Walt Disney (DIS) and Gilead Sciences (GILD).

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita's stock is owned by a variety of retail and institutional investors. Top institutional investors include Wedge Capital Management L L P NC (0.36%), Envestnet Asset Management Inc. (0.17%), Hexavest Inc. (0.14%), Municipal Employees Retirement System of Michigan (0.01%), Exane Derivatives (0.00%) and Acorn Financial Advisory Services Inc. ADV (0.00%). Company insiders that own Davita stock include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway and Paul J Diaz. View institutional ownership trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Envestnet Asset Management Inc., and Acorn Financial Advisory Services Inc. ADV. Company insiders that have sold Davita company stock in the last year include Charles Berg, John M Nehra, Kent J Thiry, Pamela M Arway, and Paul J Diaz. View insider buying and selling activity for Davita.

DVA stock was purchased by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, Exane Derivatives, and Wedge Capital Management L L P NC. View insider buying and selling activity for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $79.74.

Davita has a market capitalization of $9.71 billion and generates $11.39 billion in revenue each year. The company earns $810.98 million in net income (profit) each year or $5.40 on an earnings per share basis. Davita employs 65,000 workers across the globe.

The official website for Davita is www.davita.com.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]